• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定剂可通过数字 PCR 防止血液样本储存和运输过程中血浆中细胞游离 DNA 对细胞 DNA 的污染。

A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR.

机构信息

Research and Development Division, Streck Inc., Omaha, NE 68128, USA.

出版信息

Clin Biochem. 2013 Oct;46(15):1561-5. doi: 10.1016/j.clinbiochem.2013.06.002. Epub 2013 Jun 13.

DOI:10.1016/j.clinbiochem.2013.06.002
PMID:23769817
Abstract

OBJECTIVES

To study the ability of a stabilizing reagent to prevent cellular DNA contamination of cell-free DNA (cfDNA) in plasma during whole blood sample storage and shipping.

DESIGN AND METHODS

Samples were drawn from healthy donors into K₃EDTA and Cell-Free DNA BCTs (BCT) and stored at room temperature (RT). Aliquots were removed at specified time points and cfDNA was purified from the plasma. A Droplet Digital PCR (ddPCR) assay that amplifies a short β-actin gene fragment (136 bp) was used to measure the total plasma cfDNA (pDNA) concentration while a longer β-actin fragment (420 bp) was used to quantify genomic DNA (gDNA). In a follow-up experiment, blood samples drawn into the same types of tubes were shipped round trip by overnight air before cfDNA was isolated and analyzed.

RESULTS

Blood stored in K₃EDTA tubes at RT showed increases in pDNA and gDNA concentrations over time. However, both pDNA and gDNA levels remained stable in BCT for at least seven days. On day 14, there was a 4.5-fold increase in pDNA in BCT as compared to >200-fold increase in K₃EDTA tubes. Likewise, gDNA increased <2-fold on day 14 in BCT as opposed to a 456-fold increase in K₃EDTA tubes. Similar results were observed after samples were shipped.

CONCLUSIONS

Cell-Free DNA BCTs prevent gDNA contamination that may occur due to nucleated cell disruption during sample storage and shipping. This novel blood collection tube provides a method for obtaining stable cfDNA samples for rare target detection and accurate analysis while mitigating the threat of gDNA contamination.

摘要

目的

研究一种稳定剂在全血样本储存和运输过程中防止游离 DNA(cfDNA)细胞内 DNA 污染的能力。

设计与方法

从健康供体中抽取样本至 K₃EDTA 和游离 DNA BCT(BCT)管中,并在室温下储存。在规定的时间点取出等分试样,并从血浆中纯化 cfDNA。使用扩增短β-肌动蛋白基因片段(136bp)的液滴数字 PCR(ddPCR)测定法测量总血浆 cfDNA(pDNA)浓度,而较长的β-肌动蛋白片段(420bp)则用于定量基因组 DNA(gDNA)。在后续实验中,将相同类型的管中的血液样本通过隔夜空运来回运输,然后分离和分析 cfDNA。

结果

在 RT 下储存在 K₃EDTA 管中的血液随时间推移 pDNA 和 gDNA 浓度增加。然而,BCT 中 pDNA 和 gDNA 水平至少在七天内保持稳定。在 BCT 中,与 K₃EDTA 管中 >200 倍的增加相比,第 14 天 pDNA 增加了 4.5 倍。同样,BCT 中 gDNA 在第 14 天增加了 <2 倍,而 K₃EDTA 管中增加了 456 倍。在样本运输后也观察到了类似的结果。

结论

游离 DNA BCT 可防止因样本储存和运输过程中核细胞破裂而导致的 gDNA 污染。这种新型血液采集管为获取稳定的 cfDNA 样本以进行稀有靶标检测和准确分析提供了一种方法,同时减轻了 gDNA 污染的威胁。

相似文献

1
A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR.稳定剂可通过数字 PCR 防止血液样本储存和运输过程中血浆中细胞游离 DNA 对细胞 DNA 的污染。
Clin Biochem. 2013 Oct;46(15):1561-5. doi: 10.1016/j.clinbiochem.2013.06.002. Epub 2013 Jun 13.
2
A new blood collection device minimizes cellular DNA release during sample storage and shipping when compared to a standard device.与标准设备相比,新型血液采集装置可最大限度减少样本储存和运输过程中的细胞 DNA 释放。
J Clin Lab Anal. 2013 Jul;27(4):305-11. doi: 10.1002/jcla.21603.
3
Performance comparison of blood collection tubes as liquid biopsy storage system for minimizing cfDNA contamination from genomic DNA.作为液体活检存储系统的采血管在将循环游离DNA(cfDNA)受基因组DNA污染降至最低方面的性能比较
J Clin Lab Anal. 2019 Feb;33(2):e22670. doi: 10.1002/jcla.22670. Epub 2018 Sep 7.
4
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.用于液体活检检测的Streck循环游离DNA血液采集管的性能
PLoS One. 2016 Nov 10;11(11):e0166354. doi: 10.1371/journal.pone.0166354. eCollection 2016.
5
Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing.优化游离 DNA 的采集、运输和储存条件可增加产前检测的机会。
Clin Biochem. 2013 Aug;46(12):1099-1104. doi: 10.1016/j.clinbiochem.2013.04.023. Epub 2013 Apr 30.
6
Effects of a novel cell stabilizing reagent on DNA amplification by PCR as compared to traditional stabilizing reagents.与传统稳定剂相比,一种新型细胞稳定剂对PCR扩增DNA的影响。
Acta Histochem. 2014 Jan;116(1):55-60. doi: 10.1016/j.acthis.2013.05.002. Epub 2013 Jun 28.
7
Real-time PCR evaluation of cell-free DNA subjected to various storage and shipping conditions.对处于各种储存和运输条件下的游离DNA进行实时聚合酶链反应评估。
Genet Mol Res. 2015 Oct 19;14(4):12797-804. doi: 10.4238/2015.October.19.23.
8
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.循环肿瘤DNA在临床肿瘤学前瞻性试验中的应用——分析前条件的标准化
Mol Oncol. 2017 Mar;11(3):295-304. doi: 10.1002/1878-0261.12037. Epub 2017 Feb 22.
9
Influence of temperature during transportation on cell-free DNA analysis.运输过程中温度对游离 DNA 分析的影响。
Fetal Diagn Ther. 2012;31(2):122-8. doi: 10.1159/000335020. Epub 2012 Jan 19.
10
A novel blood collection device stabilizes cell-free RNA in blood during sample shipping and storage.一种新型采血装置可在样本运输和储存过程中稳定血液中的游离RNA。
BMC Res Notes. 2013 Sep 26;6:380. doi: 10.1186/1756-0500-6-380.

引用本文的文献

1
Monitoring breast cancer progression through circulating methylated GCM2 and TMEM240 detection.通过检测循环中的甲基化GCM2和TMEM240监测乳腺癌进展。
Clin Epigenetics. 2025 Jul 21;17(1):128. doi: 10.1186/s13148-025-01939-4.
2
Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.循环游离DNA检测与分析技术进展在患者护理个性化医疗中的应用
Biomolecules. 2024 Apr 19;14(4):498. doi: 10.3390/biom14040498.
3
Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
结直肠癌循环核酸:诊断和预后价值。
Dis Markers. 2024 Feb 13;2024:9943412. doi: 10.1155/2024/9943412. eCollection 2024.
4
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment.三阴性乳腺癌循环肿瘤突变检测作为组织反应评估的辅助手段
NPJ Breast Cancer. 2024 Jan 5;10(1):3. doi: 10.1038/s41523-023-00607-1.
5
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.用于常规病理实践中肿瘤诊断的优化全基因组测序工作流程。
Nat Protoc. 2024 Mar;19(3):700-726. doi: 10.1038/s41596-023-00933-5. Epub 2023 Dec 13.
6
ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma.循环肿瘤DNA作为一种用于癌症诊断的新型且有前景的方法:聚焦于肝细胞癌
EXCLI J. 2023 Aug 3;22:752-780. doi: 10.17179/excli2023-6277. eCollection 2023.
7
Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis.激素敏感性乳腺癌中用于ESR1突变分析的液体活检验证:一项汇总荟萃分析
Front Oncol. 2023 Aug 22;13:1221773. doi: 10.3389/fonc.2023.1221773. eCollection 2023.
8
False Positives in Brucellosis Serology: Wrong Bait and Wrong Pond?布鲁氏菌病血清学中的假阳性:诱饵错误与“池塘”错误?
Trop Med Infect Dis. 2023 May 12;8(5):274. doi: 10.3390/tropicalmed8050274.
9
Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology.用于肿瘤液体分析的Streck游离DNA血液采集管的分析前评估
Diagnostics (Basel). 2023 Mar 29;13(7):1288. doi: 10.3390/diagnostics13071288.
10
Clinical Circulating Tumor DNA Testing for Precision Oncology.临床循环肿瘤 DNA 检测在精准肿瘤学中的应用。
Cancer Res Treat. 2023 Apr;55(2):351-366. doi: 10.4143/crt.2022.1026.